U.S. Tortugas Neuroscience Raises $106 Million and Fully Launches
Tortugas Neuroscience, a US biotech focused on CNS disorders, raised $106 million in Seed and Series… · 2026-04-22
Tortugas Neuroscience, a US biotech focused on CNS disorders, raised $106 million in Seed and Series… · 2026-04-22
Ken Horn, Managing Partner at AN Venture Partners, has been appointed to the Advisory Board of the J… · 2026-06-15
AN Venture Partners (ANV), a global biotechnology venture capital firm, announced the appointment of… · 2026-04-01
Tortugas Neuroscience, a US biotech focused on CNS disorders, raised $106 million in Seed and Series… · 2026-04-22
AN Venture Partners (ANV), a global biotechnology venture capital firm, announced the appointment of… · 2026-04-01
AN Venture Partners (ANV), a global biotechnology venture capital firm, announced the appointment of… · 2026-04-01